Oxcarbazepine Extended Release
Measure-based Guidance
Collaborative Care Initiative, LLCPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Measure-based Guidance cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxcarbamezapine Collaborative Care Initiative, LLC | Phase 4 | BB |
Same molecule, other indications
Oxcarbazepine Extended Release is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →